ID   S29A2_HUMAN             Reviewed;         456 AA.
AC   Q14542; B3KPY7; O43530; Q52M84; Q96R00; Q9UPE0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Equilibrative nucleoside transporter 2;
DE   AltName: Full=36 kDa nucleolar protein HNP36;
DE   AltName: Full=Delayed-early response protein 12;
DE   AltName: Full=Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter;
DE            Short=Equilibrative NBMPR-insensitive nucleoside transporter;
DE   AltName: Full=Hydrophobic nucleolar protein, 36 kDa;
DE   AltName: Full=Nucleoside transporter, ei-type;
DE   AltName: Full=Solute carrier family 29 member 2;
GN   Name=SLC29A2; Synonyms=DER12, ENT2, HNP36;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=7639753; DOI=10.1006/bbrc.1995.2133;
RA   Williams J.B., Lanahan A.A.;
RT   "A mammalian delayed-early response gene encodes HNP36, a novel,
RT   conserved nucleolar protein.";
RL   Biochem. Biophys. Res. Commun. 213:325-333(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9396714; DOI=10.1042/bj3280739;
RA   Griffiths M., Yao S.Y., Abidi F., Phillips S.E., Cass C.E.,
RA   Young J.D., Baldwin S.A.;
RT   "Molecular cloning and characterization of a nitrobenzylthioinosine-
RT   insensitive (ei) equilibrative nucleoside transporter from human
RT   placenta.";
RL   Biochem. J. 328:739-743(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND RESPONSE TO NBMPR.
RX   PubMed=9478986; DOI=10.1074/jbc.273.9.5288;
RA   Crawford C.R., Patel D.H., Naeve C., Belt J.A.;
RT   "Cloning of the human equilibrative, nitrobenzylmercaptopurine
RT   riboside (NBMPR)-insensitive nucleoside transporter ei by functional
RT   expression in a transport-deficient cell line.";
RL   J. Biol. Chem. 273:5288-5293(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS
RP   OF LEU-455 AND LEU-456.
RX   PubMed=12527552;
RA   Mangravite L.M., Xiao G., Giacomini K.M.;
RT   "Localization of human equilibrative nucleoside transporters, hENT1
RT   and hENT2, in renal epithelial cells.";
RL   Am. J. Physiol. 284:F902-F910(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   GLYCOSYLATION AT ASN-48 AND ASN-57.
RX   PubMed=12590919; DOI=10.1016/S0003-9861(02)00718-X;
RA   Ward J.L., Leung G.P., Toan S.V., Tse C.-M.;
RT   "Functional analysis of site-directed glycosylation mutants of the
RT   human equilibrative nucleoside transporter-2.";
RL   Arch. Biochem. Biophys. 411:19-26(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   VARIANTS TYR-5; LYS-68; LEU-94 AND 184-SER--VAL-186 DELINS MET.
RX   PubMed=16214850; DOI=10.1124/dmd.105.006270;
RA   Owen R.P., Lagpacan L.L., Taylor T.R., De La Cruz M., Huang C.C.,
RA   Kawamoto M., Johns S.J., Stryke D., Ferrin T.E., Giacomini K.M.;
RT   "Functional characterization and haplotype analysis of polymorphisms
RT   in the human equilibrative nucleoside transporter, ENT2.";
RL   Drug Metab. Dispos. 34:12-15(2006).
CC   -!- FUNCTION: Mediates equilibrative transport of purine, pyrimidine
CC       nucleosides and the purine base hypoxanthine. Very less sensitive
CC       than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR),
CC       dipyridamole, dilazep and draflazine.
CC       {ECO:0000269|PubMed:9396714}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.2 mM for uridine {ECO:0000269|PubMed:12527552,
CC         ECO:0000269|PubMed:9396714};
CC         KM=0.75 mM for adenosine {ECO:0000269|PubMed:12527552,
CC         ECO:0000269|PubMed:9396714};
CC         Note=Vmax for adenosine uptake is about the same for SLC29A1 and
CC         SLC29A2.;
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:12527552}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12527552}. Nucleus membrane
CC       {ECO:0000269|PubMed:12527552}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12527552}. Note=Localized at the basolateral
CC       cell membrane in polarized MDCK cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q14542-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, HNP36;
CC         IsoId=Q14542-2; Sequence=VSP_040728, VSP_040729;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q14542-3; Sequence=VSP_040730, VSP_040731;
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, liver, lung,
CC       placenta, brain, heart, kidney and ovarian tissues.
CC       {ECO:0000269|PubMed:12527552, ECO:0000269|PubMed:9396714}.
CC   -!- INDUCTION: By PDGF/platelet derived growth factor and fibroblast
CC       growth factor (FGF).
CC   -!- SIMILARITY: Belongs to the SLC29A/ENT transporter (TC 2.A.57)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA60380.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X86681; CAA60380.1; ALT_SEQ; mRNA.
DR   EMBL; AF029358; AAC39526.1; -; mRNA.
DR   EMBL; AF034102; AAB97834.1; -; mRNA.
DR   EMBL; AK057041; BAG51849.1; -; mRNA.
DR   EMBL; AF401235; AAK92533.1; -; mRNA.
DR   EMBL; AP001107; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74521.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74519.1; -; Genomic_DNA.
DR   EMBL; BC093634; AAH93634.1; -; mRNA.
DR   CCDS; CCDS8137.1; -. [Q14542-1]
DR   PIR; JC4196; JC4196.
DR   RefSeq; NP_001287797.1; NM_001300868.1. [Q14542-1]
DR   RefSeq; NP_001523.2; NM_001532.2. [Q14542-1]
DR   RefSeq; XP_016873121.1; XM_017017632.1. [Q14542-1]
DR   UniGene; Hs.569017; -.
DR   UniGene; Hs.736345; -.
DR   ProteinModelPortal; Q14542; -.
DR   BioGrid; 109419; 2.
DR   IntAct; Q14542; 1.
DR   STRING; 9606.ENSP00000350024; -.
DR   BindingDB; Q14542; -.
DR   ChEMBL; CHEMBL3509606; -.
DR   DrugBank; DB00900; Didanosine.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00441; Gemcitabine.
DR   DrugBank; DB01033; Mercaptopurine.
DR   DrugBank; DB00943; Zalcitabine.
DR   DrugBank; DB00495; Zidovudine.
DR   TCDB; 2.A.57.1.8; the equilibrative nucleoside transporter (ent) family.
DR   iPTMnet; Q14542; -.
DR   PhosphoSitePlus; Q14542; -.
DR   BioMuta; SLC29A2; -.
DR   DMDM; 116242781; -.
DR   EPD; Q14542; -.
DR   MaxQB; Q14542; -.
DR   PaxDb; Q14542; -.
DR   PeptideAtlas; Q14542; -.
DR   PRIDE; Q14542; -.
DR   Ensembl; ENST00000357440; ENSP00000350024; ENSG00000174669. [Q14542-1]
DR   Ensembl; ENST00000540386; ENSP00000444870; ENSG00000174669. [Q14542-3]
DR   Ensembl; ENST00000541567; ENSP00000442116; ENSG00000174669. [Q14542-2]
DR   Ensembl; ENST00000544554; ENSP00000439456; ENSG00000174669. [Q14542-1]
DR   Ensembl; ENST00000546034; ENSP00000440329; ENSG00000174669. [Q14542-1]
DR   GeneID; 3177; -.
DR   KEGG; hsa:3177; -.
DR   UCSC; uc001oht.4; human. [Q14542-1]
DR   CTD; 3177; -.
DR   DisGeNET; 3177; -.
DR   GeneCards; SLC29A2; -.
DR   HGNC; HGNC:11004; SLC29A2.
DR   HPA; HPA018168; -.
DR   MIM; 602110; gene.
DR   neXtProt; NX_Q14542; -.
DR   OpenTargets; ENSG00000174669; -.
DR   PharmGKB; PA191; -.
DR   eggNOG; KOG1479; Eukaryota.
DR   eggNOG; ENOG410Y3MT; LUCA.
DR   GeneTree; ENSGT00390000002232; -.
DR   HOGENOM; HOG000007684; -.
DR   HOVERGEN; HBG074626; -.
DR   InParanoid; Q14542; -.
DR   KO; K15014; -.
DR   OMA; FNIMDCL; -.
DR   OrthoDB; EOG091G09WB; -.
DR   PhylomeDB; Q14542; -.
DR   TreeFam; TF313950; -.
DR   Reactome; R-HSA-83936; Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane.
DR   GeneWiki; Equilibrative_nucleoside_transporter_2; -.
DR   GenomeRNAi; 3177; -.
DR   PRO; PR:Q14542; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000174669; -.
DR   CleanEx; HS_SLC29A2; -.
DR   ExpressionAtlas; Q14542; baseline and differential.
DR   Genevisible; Q14542; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005337; F:nucleoside transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0015858; P:nucleoside transport; IDA:UniProtKB.
DR   InterPro; IPR034764; ENT1/ENT2.
DR   InterPro; IPR030197; ENT2.
DR   InterPro; IPR002259; Eqnu_transpt.
DR   InterPro; IPR020846; MFS_dom.
DR   PANTHER; PTHR10332; PTHR10332; 1.
DR   PANTHER; PTHR10332:SF57; PTHR10332:SF57; 1.
DR   Pfam; PF01733; Nucleoside_tran; 1.
DR   PIRSF; PIRSF016379; ENT; 1.
DR   PRINTS; PR01130; DERENTRNSPRT.
DR   SUPFAM; SSF103473; SSF103473; 2.
DR   TIGRFAMs; TIGR00939; 2a57; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Membrane; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    456       Equilibrative nucleoside transporter 2.
FT                                /FTId=PRO_0000209340.
FT   TRANSMEM     13     33       Helical. {ECO:0000255}.
FT   TRANSMEM     70     90       Helical. {ECO:0000255}.
FT   TRANSMEM     99    119       Helical. {ECO:0000255}.
FT   TRANSMEM    124    144       Helical. {ECO:0000255}.
FT   TRANSMEM    162    182       Helical. {ECO:0000255}.
FT   TRANSMEM    193    213       Helical. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TRANSMEM    360    380       Helical. {ECO:0000255}.
FT   TRANSMEM    386    406       Helical. {ECO:0000255}.
FT   TRANSMEM    432    452       Helical. {ECO:0000255}.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12590919}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12590919}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      93    202       VPETVRILGSLLAILLLFALTAALVKVDMSPGPFFSITMAS
FT                                VCFINSFSAVLQGSLFGQLGTMPSTYSTLFLSGQGLAGIFA
FT                                ALAMLLSMASGVDAETSALGYFITPCVG -> AGQGGHEPR
FT                                TLLLHHHGLRLLHQLLQCSPTGQPLRAAGHHALHLQHPLPQ
FT                                RPGPGWDLCCPCHAPVHGQWRGRRDLCPGVLYHALCGHPHV
FT                                HRVLPEPASPEVCPLLPGQ (in isoform 2).
FT                                {ECO:0000303|PubMed:7639753}.
FT                                /FTId=VSP_040728.
FT   VAR_SEQ     203    456       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7639753}.
FT                                /FTId=VSP_040729.
FT   VAR_SEQ     290    301       IWLTALCLVLVF -> SPCPSSPPSQPW (in isoform
FT                                3). {ECO:0000303|PubMed:12527552}.
FT                                /FTId=VSP_040730.
FT   VAR_SEQ     302    456       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12527552}.
FT                                /FTId=VSP_040731.
FT   VARIANT       5      5       D -> Y (in dbSNP:rs8187643).
FT                                {ECO:0000269|PubMed:16214850}.
FT                                /FTId=VAR_029289.
FT   VARIANT      68     68       N -> K (in dbSNP:rs8187644).
FT                                {ECO:0000269|PubMed:16214850}.
FT                                /FTId=VAR_029290.
FT   VARIANT      94     94       P -> L (in dbSNP:rs8187648).
FT                                {ECO:0000269|PubMed:16214850}.
FT                                /FTId=VAR_029291.
FT   VARIANT     184    186       SGV -> M. {ECO:0000269|PubMed:16214850}.
FT                                /FTId=VAR_036822.
FT   MUTAGEN     455    455       L->R: Reduces drastically localization at
FT                                the cell surface. No effect on uptake of
FT                                adenosine and thymidine. Reduces
FT                                drastically localization at the cell
FT                                surface and induces an significant
FT                                reduction of adenosine or thymidine
FT                                uptake; when associated with R-456.
FT                                {ECO:0000269|PubMed:12527552}.
FT   MUTAGEN     456    456       L->R: Reduces drastically localization at
FT                                the cell surface and induces an
FT                                significant reduction of adenosine or
FT                                thymidine uptake; when associated with R-
FT                                455. {ECO:0000269|PubMed:12527552}.
FT   CONFLICT    200    200       C -> Y (in Ref. 1; CAA60380 and 2;
FT                                AAC39526). {ECO:0000305}.
SQ   SEQUENCE   456 AA;  50113 MW;  ABCBD244306708E1 CRC64;
     MARGDAPRDS YHLVGISFFI LGLGTLLPWN FFITAIPYFQ ARLAGAGNST ARILSTNHTG
     PEDAFNFNNW VTLLSQLPLL LFTLLNSFLY QCVPETVRIL GSLLAILLLF ALTAALVKVD
     MSPGPFFSIT MASVCFINSF SAVLQGSLFG QLGTMPSTYS TLFLSGQGLA GIFAALAMLL
     SMASGVDAET SALGYFITPC VGILMSIVCY LSLPHLKFAR YYLANKSSQA QAQELETKAE
     LLQSDENGIP SSPQKVALTL DLDLEKEPES EPDEPQKPGK PSVFTVFQKI WLTALCLVLV
     FTVTLSVFPA ITAMVTSSTS PGKWSQFFNP ICCFLLFNIM DWLGRSLTSY FLWPDEDSRL
     LPLLVCLRFL FVPLFMLCHV PQRSRLPILF PQDAYFITFM LLFAVSNGYL VSLTMCLAPR
     QVLPHEREVA GALMTFFLAL GLSCGASLSF LFKALL
//
